FDA Commissioner Margaret A. Hamburg, M.D., today released a blueprint containing immediate steps that can be taken to drive biomedical innovation, while improving the health of Americans.
TigerTox: Why Drug Safety Should Not Take a Back Seat to Efficacy http://t. كيفية لعب لعبة بينجو co/CNiG0o5v #in #pharma RT @PLoSMedicine
TigerTox: Key strategic choices – ‘what’ to develop in #pharma | http://t. ivermectin paste dosage for swine co/ZYOO5npz . RT @NatureBiotech @FierceBioTech #in
FDA’s Center for Devices and Radiological Health (CDRH) is soliciting comment on a plan to create a network of outside scientific experts who would provide staff with rapid access to specific specialized knowledge about emerging technology, as well as other topics....
TigerTox: Open-access R&D 1 answer to drug industry woes | http://t. ivermectin and pregnant goats co/vBQs5myp #in #pharma #preclinical RT @reutersBenHir
